About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
ASCO/ESMO Update on Locally Advanced HNSCC: Does the anti-PD1 Pembro Concomitant With RT Improve Carcinologic Outcomes vs. SOC Cetuximab-RT?
By
GRACE
FEATURING
Joshua Bauml
,
Jared Weiss
,
Kathryn Gold
,
Ranee Mehra
By
GRACE
FEATURING
Joshua Bauml
,
Jared Weiss
,
Kathryn Gold
,
Ranee Mehra
149 views
January 30, 2021
0 Comments
Login to view comments.
Click here to Login
Related Content
AUTOPLAY
ON
27:04
Fengting Yan
Cancer Screening Molecular Tools
26:19
Ammar Sukari
Nasopharyngeal Carcinoma: Clinical Overview & Disease Management
18:07
Nebraska Oncology Society
NOS ASCO® 2023 Review: Nasopharynx Cancer
Feat.
E. Sherman
13:06
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Summary: "Key H&N Cancer Studies Including FRAIL…
Feat.
P. Bossi
12:02
Insights from 2023 IFHNOS Annual Meeting
IFHNOS 2023 Insights: "Personalized (Precision) Medicine in Hea…
Feat.
C. Stratakis
26:51
Paolo Bossi
Year in Review: Head & Neck Cancers
14:56
Insights from 2023 ESMO Annual Meeting
ESMO 2023 Summary: "Key H&N Cancer Updates"
Feat.
P. Bossi
23:38
2023 West Oncology Conference
Improving the Quality of Life for Head & Neck Cancer Survivors: …
Feat.
B. Murphy
06:11
ecancer
ASCO® 2023 Insights: "Key Head & Neck Data"
Feat.
G. Hanna
54:42
UNC Lineberger Comprehensive Cancer Center
2023 UNC Head and Neck Cancer Management Updates
Feat.
J. Weiss,
S. Sheth,
W. Yarbrough,
C. Shen
15:11
Insights from 2023 ASCO® Annual Meeting
Immunotherapy Trials for Nasopharyngeal Cancers
Feat.
N. Saba
04:33
GRACE
Treatment Options for Patients With Head & Neck Cancer and High …
Feat.
J. Weiss
04:46
GRACE
Emerging Treatment Options for Head and Neck Cancer
Feat.
J. Weiss
26:29
City of Hope
Treatment Approaches to Locally Advanced Nasopharyngeal Carcinoma: C…
Feat.
V. Villaflor
19:57
Michael Gibson
AHNS 2023 Insights: "HNSCC Updates - Tumor Microenvironment, Ne…
06:27
Insights from 2023 ASCO® Annual Meeting
Enfortumab Vedotin in the Previously Treated Advanced Head & Nec…
Feat.
P. Swiecicki
47:34
Fred Hutch 13th Annual Comprehensive Hematology & Oncology Review Course
Fred Hutchinson Cancer Center Head & Neck Cancer Updates
Feat.
C. Rodriguez
10:16
ESMO 2022 Conference Coverage
ESMO 2022 H&N Updates
Feat.
N. Saba
29:25
Young Chae
Hyperprogression in Cancer Treated With Immunotherapy
24:55
MedNews Week
Recent Advancements in IO Therapy for Head and Neck Cancers
Feat.
E. Cohen
